Xofigo pharmaceuticals

Ended Awarded Last action

Contract number
36C25020F0175
Awardee
Awarding agency
Obligated
$90,215

Award facts

Contract value 100% obligated
$90,214.74 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Dayton, OH 45428, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $90,215

About this award

This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, for the delivery of XOFIGO, a specialized radiopharmaceutical product for the treatment of prostate cancer. The contract, valued at $90,214.74, was awarded by the Department of Veterans Affairs (VA) on October 23, 2019, with a completion date of May 31, 2020. The contract is a delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which allows various federal agencies to place orders for a broad range of pharmaceutical products. Bayer Healthcare Pharmaceuticals Inc. holds several significant federal contract vehicles with the VA and the Defense Logistics Agency (DLA) Troop Support Medical, enabling the company to provide a comprehensive range of pharmaceutical and medical products to support healthcare programs for veterans, active-duty military personnel, and federal medical facilities. This contract award does not have a set-aside designation.

Quick answers

Who was awarded contract 36C25020F0175?

36C25020F0175 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 23, 2019.

How much is contract 36C25020F0175 worth?

The government has obligated $90,215 on 36C25020F0175.

Is contract 36C25020F0175 an order under another contract?

Yes. 36C25020F0175 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25020F0175 competed?

The extent of competition for 36C25020F0175 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award